OBJECTIVE: Knowledge of potentially modifiable risk factors for neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) is important. This study longitudinally explores modifiable vascular risk factors for NPS in AD. METHODS: Participants enrolled in the Cache County Study on Memory in Aging with no dementia at baseline were subsequently assessed over three additional waves, and those with incident (new onset) dementia were invited to join the Dementia Progression Study for longitudinal follow-up. A total of 327 participants with incident AD were identified and assessed for the following vascular factors: atrial fibrillation, hypertension, diabetes mellitus, angina, coronary artery bypass surgery, myocardial infarction, cerebrovascular accident, and use of antihypertensive or diabetes medicines. A vascular index (VI) was also calculated. NPS were assessed over time using the Neuropsychiatric Inventory (NPI). Affective and Psychotic symptom clusters were assessed separately. The association between vascular factors and change in NPI total score was analyzed using linear mixed model and in symptom clusters using a random effects model. RESULTS: No individual vascular risk factors or the VI significantly predicted change in any individual NPS. The use of antihypertensive medications more than four times per week was associated with higher total NPI and Affective cluster scores. CONCLUSIONS: Use of antihypertensive medication was associated with higher total NPI and Affective cluster scores. The results of this study do not otherwise support vascular risk factors as modifiers of longitudinal change in NPS in AD.
OBJECTIVE: Knowledge of potentially modifiable risk factors for neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) is important. This study longitudinally explores modifiable vascular risk factors for NPS in AD. METHODS:Participants enrolled in the Cache County Study on Memory in Aging with no dementia at baseline were subsequently assessed over three additional waves, and those with incident (new onset) dementia were invited to join the Dementia Progression Study for longitudinal follow-up. A total of 327 participants with incident AD were identified and assessed for the following vascular factors: atrial fibrillation, hypertension, diabetes mellitus, angina, coronary artery bypass surgery, myocardial infarction, cerebrovascular accident, and use of antihypertensive or diabetes medicines. A vascular index (VI) was also calculated. NPS were assessed over time using the Neuropsychiatric Inventory (NPI). Affective and Psychotic symptom clusters were assessed separately. The association between vascular factors and change in NPI total score was analyzed using linear mixed model and in symptom clusters using a random effects model. RESULTS: No individual vascular risk factors or the VI significantly predicted change in any individual NPS. The use of antihypertensive medications more than four times per week was associated with higher total NPI and Affective cluster scores. CONCLUSIONS: Use of antihypertensive medication was associated with higher total NPI and Affective cluster scores. The results of this study do not otherwise support vascular risk factors as modifiers of longitudinal change in NPS in AD.
Authors: J S Paulsen; D P Salmon; L J Thal; R Romero; C Weisstein-Jenkins; D Galasko; C R Hofstetter; R Thomas; I Grant; D V Jeste Journal: Neurology Date: 2000-05-23 Impact factor: 9.910
Authors: C G Lyketsos; J M Sheppard; M Steinberg; J A Tschanz; M C Norton; D C Steffens; J C Breitner Journal: Int J Geriatr Psychiatry Date: 2001-11 Impact factor: 3.485
Authors: M M Bassiony; M S Steinberg; A Warren; A Rosenblatt; A S Baker; C G Lyketsos Journal: Int J Geriatr Psychiatry Date: 2000-02 Impact factor: 3.485
Authors: JoAnn T Tschanz; Kathleen A Welsh-Bohmer; Brenda L Plassman; Maria C Norton; Bonita W Wyse; John C S Breitner Journal: Neuropsychiatry Neuropsychol Behav Neurol Date: 2002-03
Authors: Corinne E Fischer; Winnie Qian; Tom A Schweizer; Colleen P Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; Paul Shelton; David G Munoz Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Elizabeth K Vernon; Bryce Cooley; William Rozum; Gail B Rattinger; Stephanie Behrens; Joshua Matyi; Elizabeth Fauth; Constantine G Lyketsos; JoAnn T Tschanz Journal: Am J Geriatr Psychiatry Date: 2018-12-01 Impact factor: 4.105
Authors: Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard Journal: Nat Rev Neurol Date: 2022-01-04 Impact factor: 44.711
Authors: Kristoffer H Hellton; Jeffrey Cummings; Audun Osland Vik-Mo; Jan Erik Nordrehaug; Dag Aarsland; Geir Selbaek; Lasse Melvaer Giil Journal: Multivariate Behav Res Date: 2020-04-24 Impact factor: 5.923